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Viral pathogens have threatened human being's health for a long time, from periodically breakout ﬂu epidemics to recent rising Ebola virus
disease. Herein, we report a new application of nonstoichiometric Perovskite-type LaxMnO3 (x¼1, 0.95, and 0.9) compounds in spontaneous and
continuous disinfection of viruses. Perovskite-type LaxMnO3 (x¼1, 0.95, and 0.9) is well-known for their catalytic properties involving
oxidization reactions, which are usually utilized as electrodes in fuel cells. By utilizing superb oxidative ability of LaxMnO3 (x¼1, 0.95, and 0.9),
amino acid residues in viral envelope proteins are oxidized, thus envelope proteins are denatured and infectivity of the virus is neutralized. It is of
great importance that this process does not require external energy sources like light or heat. The A/PR/8/34H1N1 inﬂuenza A virus (PR8) was
employed as the sample virus in our demonstration, and high-throughput disinfections were observed. The efﬁciency of disinfection was
correlated to oxidative ability of LaxMnO3 (x¼1, 0.95, and 0.9) by EPR and H2-TPR results that La0.9MnO3 had the highest oxidative ability and
correspondingly gave out the best disinfecting results within three nonstoichiometric compounds. Moreover, denaturation of hemagglutinin and
neuraminidase, the two key envelope proteins of inﬂuenza A viruses, was demonstrated by HA unit assay with chicken red blood cells and NA
ﬂuorescence assay, respectively. This unique disinfecting application of La0.9MnO3 is considered as a great make up to current sterilizing
methods especially to photocatalyst based disinfectants and can be widely applied to cut-off spread routes of viruses, either viral aerosol or
contaminated ﬂuid, and help in controlling the possibly upcoming epidemics like ﬂus and hemorrhagic fever.
& 2015 Chinese Materials Research Society. Production and hosting by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Viral pathogens have resulted in many several diseases to
human beings, like ﬂu, ADIS, hepatitis, hemorrhagic fever,
etc., which remain as threatens even with today's medical
development [1–5]. Taking ﬂu pandemics as the example, its
severity has been recorded since the 1918 Spanish pandemic,
the most serious ﬂu pandemic in human history [1,6].10.1016/j.pnsc.2015.05.003
15 Chinese Materials Research Society. Production and hosting by
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nder responsibility of Chinese Materials Research Society.Preventing the irregular outbreak and controlling the rapid
spreading of ﬂu pandemic have attracted great interest in
research community, as a result, antiviral drugs and vaccines
are considered as the most effective in vivo solutions [7].
However, continue mutating of viruses has brought huge
difﬁculty for human to get prepared before an outbreak taking
place. Thus cutting off the spreading pathways of viruses has
become important as the in vitro solution [8–10].
Contacting contaminated surfaces and virus-containing aerosol
have been recognized as two essential spreading pathways and
several detergents have been inspected on the purpose of
disinfecting inﬂuenza virus during their transmitting [8,11–14].
However, no matter how efﬁcient they are, it is practicallyElsevier B.V. This is an open access article under the CC BY-NC-ND license
Scheme 1. Oxidization thus disinfection of Inﬂuenza A virus by nonstoichio-
metric perovskite-type LaxMnO3 (x¼1, 0.95, and 0.9)
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ﬂowing population by chemicals or UV lights, no mention that the
human manipulation is always necessary to carry out this process.
Massive reports have been published about disinfecting
materials and nearly all of them were utilizing photocatalysts
to kill microbes, in which bacteria received more research
interests than virus did [15–22]. Brieﬂy, reactive free radicals
that are generated during light illuminating by photocatalysts,
for instance doped TiO2, AgBr–Ag–Bi2WO6 nanojuction and
our previous reported CuInS4Zn6 were utilized as mediators to
disinfect microbe sand, visible light were preferred by scien-
tists because of UV band's carcinogenic potential [23–33].
Nevertheless, it is Achilles' heel that performance of all these
photocatalysts is limited by illuminating conditions, like light
intensity, band distribution, etc. To overcome this inherent
drawback of photocatalyst based self-disinfecting surfaces, we
are considering an alternative solution that can spontaneously
disinfect virus without external energy sources, working
continuously and silently without using human workforce.
Herein, we located this problem with the outstanding
oxidative property of perovskite-type LaMnO3 [34]. Its
disinfecting ability was demonstrated on A/PR/8/34H1N1
inﬂuenza A virus as spontaneously, continuously and exter-
nal energy source freely. It is a great advantage that no
special supplies are necessary to make it work, especially
illumination or high temperature. Comparing with other
oxidative chemicals currently used in disinfection like Cl2,
HClO, KMnO4, etc. [35–39], LaMnO3 is less harsh and
superior in stability for long-term operation. To the best of
our knowledge, this is the ﬁrst report about disinfecting
ability of perovskite-type compounds without illumination.
The family of LaMnO3 compounds is one of the most
interesting members of the perovskite oxides. The research
attention to them has been attracted as compound with
colossal magneto-resistance [40,41], the cathode material
for the solid oxide fuel cells [42], and the oxidation catalyst
[43,44] since sixty years ago. It is well known that LaMnO3
exhibits promisingly higher oxidative ability comparing to
most other perovskite oxides [34,45]. Structural investiga-
tions of LaMnO3 have revealed that Mn
4þ ions are created
in LaMnO3 by the presence of vacancies in La and Mn sites
[46–49]. For further improving the oxidative ability of
LaMnO3, the partial substitution of La by other elements
and nonstoichiometry of La/Mn ratio have been extensively
studied to increase the Mn4þ ions amount by many
researchers [50,51].
As illustrated in Scheme 1, LaMnO3 is proposed to oxidize
the amino acid residues of envelope proteins on inﬂuenza
viruses, hemagglutinin (HA) and neuraminidase (NA), deacti-
vate these proteins and eventually neutralized the virus. Taken
H1N1 ﬂu virus as an instance, previous research showed that
His, Trp and Tyr were included in HA's activate site while Arg
and Tyr were in NA's [52–54], which could be easily oxidized
and result in the deactivation of entire proteins. Moreover, the
oxidative ability of LaMnO3 compounds was also up-tuned in
nonstoichiometric way as LaxMnO3 (x=1, 0.95, and 0.9) to
improve its disinfecting ability.2. Experimental section
Nonstoichiometric LaxMnO3 (x=1, 0.95, and 0.9) materials
were prepared by the citrate sol–gel method from La
(NO3)3  6H2O (Aldrich, 99.99%), Mn(NO3)2  4H2O (Aldrich,
Z97.0%) and citric acid (Aldrich, 99.5%). The solutions were
prepared in de-ionized water with cation ratio of La:Mn as 1:1,
0.95:1 and 0.9:1, respectively. Then, the citric acid was added
with 10 wt% excess over the stoichiometric quantity to insure
the complete complexation of metal ions. Hereafter, the
solutions were stirred and condensed on a heating stirrer (at
80 1C) until obtaining viscous gels. Then the gels were placed
in a vacuum oven (at 90 1C for 12 h) to form spongy raw
materials after removing nitrous vapors. Finally the raw
materials were crushed and calcined in pure oxygen (at
700 1C for 5 h with a heating rate of 10 1C min1) and ball-
milled (6 min) for further characterization.
The X-ray diffraction (XRD) patterns were obtained with an
X’Pert Pro X-ray powder diffractometer equipped with nickel-
ﬁltered Cu Kα radiation (λ=1.5418 Å). Data were collected at
45 kV and 40 mA, ranging from 201 to 701 with a 0.02 step size.
Electron paramagnetic resonance (EPR) spectra were
recorded at room temperature (RT) with a Bruker A320
spectrometer in the X band frequency (E9.78 GHz). Portions
of the samples (20 mg each) were placed inside the quartz
probe cell. Locations and the intensity of g factors were
determined by Bruker's WINEPR program based on the
hυ=gβH, where h is the Planck constant, H is the applied
magnetic ﬁeld, β is Bohr magneton.
Temperature programmed reduction (TPR) measurements
were performed in a conventional, U-shaped, quartz micro-
reactor. The samples (50 mg each) were ﬁrst heated at 500 1C
under a ﬂow of pure O2 (30 ml min
1) and kept for 30 min.
Then, the samples were cooled down to RT in the same pure
O2 ﬂow and followed by purging with helium for 30 min.
After that, the samples were heated up at a rate of 10 1C min1
Fig. 1. XRD patterns of the LaxMnO3 (x¼1, 0.95, and 0.9) samples. Peak
labels were referred to the publication of Zuo et. al. [52].
Fig. 2. EPR spectrum of the LaxMnO3 (x¼1, 0.95, and 0.9) samples.
D. Weng et al. / Progress in Natural Science: Materials International 25 (2015) 191–196 193from 50 to 800 1C under a mixed ﬂow containing 5% of H2 in
helium (30 ml min1 as overall ﬂow rate). The concentration
of H2 in the outlet gas was measured by a Balzers QMS200
quadruple spectrometer.
LaxMnO3 (x=1, 0.95, and 0.9) samples for disinfection
experiments were fabricated by drop coating as-prepared
materials (40 mg mL1in aqueous suspension) onto round
glass cover slip sand air dried over night at room temperature.
The amount of materials was marked by surface concentration,
varied from 5 to 20 mg mm2. The disinfecting ability of as-
prepared LaxMnO3 (x=1, 0.95, and 0.9) samples was examined
by TCID50 (50% tissue culture infectious dose) assay with A/
PR/8/34H1N1 inﬂuenza A virus (PR8) on Madin–Darby
canine kidney (MDCK) cell line. Cover slips coated with as-
prepared LaxMnO3 (x=1, 0.95, and 0.9) were placed into a 48
well-plate as one slip per well and empty cover slips were set
up in the same way as controls. Then PR8 solution (15 mL,
3.57 105 TCID50 mL1) was deposit onto each cover slip
and the plate was thoroughly wrapped by aluminum foil and
placed on ice to prevent PR8 from losing infectivity naturally.
Disinfection was carried out for 15 min. Finally PR8 was
eluted with sufﬁcient amount of ﬂu growth medium, 10-fold
serially diluted and sent to infect the MDCK cells. The
infectivity was calculated by the Reed–Muench method after
cells were incubated for 72 h with ﬂu growth medium. The
experiments were carried out in quadruplicate. Disinfecting
efﬁciency was characterized as relative remaining infectivity.
In hemagglutinin assay, washed pooled chicken red blood
cells (10% in Alsever's solution, Lampire Biological Labora-
tories) were diluted to 1% using PBS buffer solution right
before the experiment. After treated by as-coated slips for 2 h
(20 mg mm2 of La0.9MnO3), PR8 solution (100 mL at
3.57 105 TCID50 mL1) was added into the ﬁrst column
of a Corning V-bottom 96-well plate, which was then 2-fold
serially diluted across the 96-well plate with PBS. The ﬁnal
50 mL of solution from each well in the last column was
disposed. Then 50 mL of freshly diluted chicken red blood
cells (1%) was added to each well and mixed by gently tapping
the plate. The plate was incubated for 30 min at 4 1C and HA
Unit (HAU) was observed directly from end point of agglu-
tination phenomena. Experiments were carried out in triplicate.
Neuraminidase assays were carried out in a 48-well plate.
As-coated slips (with 20 mg mm2 of La0.9MnO3) wereimmersed in 30 uL of neuraminidase solution (1UN mL1,
Type V, from Clostridium perfringens) on ice for 1 h. Then
6 mL of solution was taken out and mixed with 50 mL of 20-(4-
Methylumbelliferyl)-α-D-N-acetyl neuraminic acid sodium salt
hydrate aqueous solution (5 mM) and 550 mL of sodium
acetate buffer (100 mM) with calcium chloride (2 mM). The
mixture was incubated at 37 1C for 30 min. Then, 200 mL of
glycine buffer (200 mM, pH 10.7) was added and the
ﬂuorescence signal from 400 to 500 nm was collected using
a Quanta Master Spectroﬂuorimeter (Photon Technology
International) with an exciting wavelength of 365 nm. The
emission intensity at 450 nm was used to compare the activity
of neuraminidase.
3. Results and discussion
Fig. 1 shows the XRD patterns of LaxMnO3 (x¼1, 0.95, and
0.9) samples calcined at 700 1C. The diffraction patterns of
LaxMnO3 are assigned to a rhombohedral perovskite-structured
oxide phase with a space group of R3̄c. It is worth noticing that
no diffraction peak of Mn3O4 phase appeared in the
La0.95MnO3 and La0.9MnO3 samples, which is in agreement
with other reports [55,56].
The electron conﬁguration of Mn4þ ions in an octahedral ﬁeld
(4A2g) allows observing their electron paramagnetic resonance
(EPR) spectra at room temperature [57]. Thus, we investigated
Mn4þ ions signal of the LaxMnO3 (x¼1, 0.95, and 0.9) samples
by EPR measurement. As shown in Fig. 2, a unique signal with g-
value around 1.99 was detected for all LaxMnO3 (x¼ , 0.95, and
0.9) samples, which was correlated with Mn4þ ions [58]. Due to
the fact that intensity of Mn4þ ions is proportion to the double
integrated area of EPR spectrum [59], we compared the concentra-
tion of Mn4þ ions among the LaxMnO3 (x¼1, 0.95, and 0.9)
samples. The double integrated area (La0.9MnO37.88 1011;
La0.95MnO32.95 1011; LaMnO31.14 1011) increased with
decreasing of La/Mn ratio. Therefore, the lower La/Mn ratio
achieved the higher concentration of Mn4þ ions in the LaxMnO3
(x¼1, 0.95, and 0.9) samples, which correlated to higher oxidative
ability [56,60].
The results of H2-TPR experiments performed on the
LaxMnO3 (x=1, 0.95, and 0.9) samples are depicted in
Fig. 3. The LaxMnO3 (x¼1, 0.95, and 0.9) samples were
Fig. 3. H2-TPR proﬁles of the LaxMnO3 (x¼1, 0.95, and 0.9) samples.
Table 1
Integrated peak area of the LaxMnO3 (x¼1, 0.95, and 0.9) samples
250–260 1C 330–340 1C 370–380 1C
LaMnO3 155 138 2716
La0.95MnO3 1722 846 2183
La0.9MnO3 2125 993 2829
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based on temperature, which indicated the multiple sites for the
reduction of perovskites. The ﬁrst peak located at the
temperature of 250–260 1C was assigned to the removal of
non-stoichiometric excess oxygen accommodated within the
lattice. The following two peaks located at 330–340 1C and
370–380 1C were attributed to the reduction of Mn4þ to Mn3þ
[60,61]. In order to further investigate the Mn4þ ions amount
in the LaxMnO3 (x=1, 0.95, and 0.9) samples, we integrated
the peak area and summarized in Table 1. It was noted that the
integrated peak area assigned to the reduction of Mn4þ to
Mn3þ in the LaxMnO3 (x¼1, 0.95, and 0.9) samples was
getting larger while the ratio of La/Mn was decreased, which
indicated the more amount of Mn4þ ions at x¼0.9 and
corresponded well to the EPR results.
The disinfecting ability of as-prepared LaxMnO3 (x¼1,
0.95, and 0.9) samples on PR8 was marked as relative
infectivity and summarized in Fig. 4. The experiments were
carried out on ice to prevent virus from losing their infectivity
naturally. It has been observed that the disinfecting ability was
increased with higher surface concentration of LaxMnO3 and
with lower La/Mn ratio (Fig. 4(a)). The best disinfection was
achieved by La0.9MnO3 (20 mg mm
2) as 76% of PR8 was
neutralized within only 15 min, while no external energy
source was supplied, included but not limited to light and
heat, also there was no special gas supplies. Speciﬁcally
4.0 103 TCID50 of virus have been disinfected, while the
airborne ID50 was reported in the range of 0.6–3.0 TCID50
[62], which suggested high-throughput disinfection and out-
standing handling ability of La0.9MnO3 coatings. Also infec-
tivity of PR8 has been reduced signiﬁcantly over time as
shown in Fig. 4(b). When viruses were eluted right after
contacting with 5 mg mm2 of La0.9MnO3, i.e. T¼0 min, the
infectivity of PR8 was not affected, which testiﬁed that the
reduced infectivity was not due to absorption betweenLaxMnO3 (x¼1, 0.95, and 0.9) and PR8 viral particles.
Meanwhile disinfecting progress was observed after different
contact durations (T¼15, 30, and 60 min), which suggested
that LaxMnO3 (x¼1, 0.95, and 0.9) continuously disinfected
the virus, and again the disinfection was not attributed to the
absorption between them, in which way the loss of infectivity
would not keep changing with time.
By correlating observed different disinfecting efﬁciencies of
LaxMnO3 (x¼1, 0.95, and 0.9) samples with oxidative ability
comparison of different La/Mn ratios, we conﬁdently believe
that the disinfection of PR8 involved the oxidative ability of
LaxMnO3 (x¼1, 0.95, and 0.9). In detail, La0.9MnO3 has best
disinfecting ability in all samples with the same concentration,
which suggested that La0.9MnO3 particles oxidized more virus
than the other two materials. On the other hand, the theoretical
calculation, the previous reports and our EPR and H2-TPR
results all suggested the maximum amount of Mn4þ ions in
La0.9MnO3 among LaxMnO3 (x¼1, 0.95, and 0.9) samples,
which indicated the highest oxidative ability of La0.9MnO3
[63–65]. Thus the best disinfecting efﬁciency of La0.9MnO3
was well explained by its highest oxidative ability.
Fig. 4 illustrates the disinfection of inﬂuenza A virus. Fig. 4(a)
shows that the disinfecting ability of LaxMnO3 (x¼1, 0.95,
and 0.9) samples was better with the increase of the surface
concentration, indicating that La0.9MnO3 had the best disinfecting
ability under the condition that 76% of PR8 was disinfected in
15 min with 20 mg mm2 of La0.9MnO3 and the infectivity of
PR8 kept decreasing with time, as shown in Fig. 4(b). Mechanism
study showed that hemagglutinin (c) and neuraminidase (d) have
been deactivated after treated by La0.9MnO3.
To further specify the mechanism behind disinfecting
phenomena, deactivation of the two critical envelope proteins
on inﬂuenza virus, hemagglutinin (HA) and neuraminidase
(NA), by as-prepared La0.9MnO3 was separately investigated.
HA could bind sialic acid receptor to introduce virus genome
into the cell and NA could cleave the sialic acid residues
therefore release the newly reproduced viral particles and
prevent them for aggregation. Deactivation of HA was
examined by testing the binding ability on red blood cells,
which was noted as HA unit (HAU). After contacting with
20 mg mm2 of La0.9MnO3 for 2 h, only half of viral HA were
working properly (Fig. 4(c)). On the other hand, activity of NA
was characterized by ﬂuorescence substrate after contacting
with 20 mg mm2 of La0.9MnO3 for 1 h. Similarly to HA, only
60% of NA's original activity got retained (Fig. 4(d)). These
results ﬁrmly testiﬁed our hypothesis. Meanwhile, the possi-
bility that the oxidative species might penetrate viral particles
and damage the genetic materials is not ruled-out [66–68],
though we do not have facility to quantify mutation of genetic
materials for current experiment with PR8. It could be a
direction in the future study.
This disinfection mechanism suggests a wide application of
La0.9MnO4 coatings because it is based on amino acid residues
but not speciﬁc proteins, lipid molecules, or gene sequences.
Most recently, rapidly rising threat from Ebola virus has widely
caught people's attention not only from academy but also publics
[5,69–74]. It is well established that VP40 is the most abundant
Fig. 4. Disinfection of inﬂuenza A virus.
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conserved amino acid motifs (L-domains) [75–77]. Increasing
evidence suggests that VP40 essentially functions as docking sites
and facilitates efﬁcient budding through interaction with cellular
protein tsg101, a vacuolar protein sorting (vps) pathway in
mammalian cells [78–86]. Structural study of VP40 ﬁnds out
that there are sensitive amino acid residues in conserved amino
acid motifs, as Asp, Glu, Gly, Leu, Arg, Thr, Val, and Tyr
[31,82,87,88]. These residues are vulnerable to oxidative stress
similar to the situation in HA and NA from inﬂuenza A virus,
thus our La0.9MnO4 coating could be able to denature the VP40
and cutoff the infection of Ebola virus from patient's body ﬂuid.
However, lack of accessible Ebola virus to us, this project is
waiting for future study.4. Conclusion
Nonstoichiometric perovskite-type LaxMnO3 (x¼1, 0.95,
and 0.9) has been successfully synthesized and demonstrated
its disinfection of the inﬂuenza A virus. This process is
spontaneous, continuous and external energy source free.
The oxidative ability of LaxMnO3 (x¼1, 0.95, and 0.9) is
tuned in different stoichiometric ratios and investigated by
EPR and H2-TPR, which La0.9MnO3 owned the best oxidative
ability and correspondingly presented the best disinfecting
efﬁciency. As a result, 76% PR8 H1N1 inﬂuenza virus was
disinfected in 15 min on the coatings containing 20 μg mm2
of La0.9MnO3, which suggested a high-throughput disinfection
and sufﬁcient handling ability. We believe that further devel-
opment of coating, molding and in situ synthesis technology
can utilize La0.9MnO3's feature of anti-pathogens in self-
disinfecting air ﬁlters and water puriﬁcation devices.Moreover, due to its oxidizing mechanism, La0.9MnO3 is
capable to disinfect wide range of pathogens, like adenovirus,
hepatitis C virus, human immunodeﬁciency virus, Ebola virus,
bacteria and even fungus, to prevent potential outbreaks of
epidemics and provide safer living environment.References
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